Global rules could cut costs and speed access to GLP-1 drugsGlobal rules could cut costs and speed access to GLP-1 drugs

FDA-approved carbon copies of brand-name drugs with expired patents—over the last 30 years, these generic drugs have saved trillions of dollars for hundreds of millions of people. FDA-approved carbon copies of brand-name drugs with expired patents—over the last 30 years, these generic drugs have saved trillions of dollars for hundreds of millions of people.
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Hello, and all hail Chonkers! Get your Alice Cooper voice ready, because school’s out for summer. But HCI is open year-round, so tell me all about your summer plans and any juicy intel you have on the health care industry: Read More
Breast cancer risk models fall short for women with family history, study findsBreast cancer risk models fall short for women with family history, study finds

Researchers from Trinity College Dublin, St James’s Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.
Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, OversightTelehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said. The 31-year-old compliance consultant from Hendersonville, Tennessee, said she couldn’t stop vomiting. “Sunday morning, it all hits,” McClain recalled, as she described what happened Read More
Younger U.S. women of color face rising breast cancer deaths, new study findsYounger U.S. women of color face rising breast cancer deaths, new study finds

Breast cancer deaths, once concentrated mostly among older women, are now claiming younger women more often, researchers recently reported in the journal npj Breast Cancer.
First comprehensive look at breast cancer in Native American women reveals key genetic differencesFirst comprehensive look at breast cancer in Native American women reveals key genetic differences

Researchers from the University of Notre Dame have published the first known detailed study of breast cancer tissue from Native American women. The study, published in npj Precision Oncology, reveals important molecular differences that may impact the efficacy of therapies for female, Native American breast cancer patients.
Gene test can safely spare many breast cancer patients of chemotherapyGene test can safely spare many breast cancer patients of chemotherapy

Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large international clinical trial led by UCL has found.
Q&A: Researcher discusses early-onset breast cancer in East AfricaQ&A: Researcher discusses early-onset breast cancer in East Africa

Most breast cancer patients in Uganda and Ethiopia are diagnosed too late, and many lack access to life-saving treatment. Tove Ekdahl Hjelm defends her thesis “Early-onset breast cancer in East Africa: genetics, tumor characteristics and clinical management” on June 5, where she highlights deficiencies in access to adequate care, but also that more lives can be saved.
No Survival Dip After Skipping Axillary Surgery for Locally Advanced Breast CancerNo Survival Dip After Skipping Axillary Surgery for Locally Advanced Breast Cancer

(MedPage Today) — CHICAGO — Skipping axillary lymph node dissection (ALND) for selected patients with locally advanced breast cancer did not adversely affect survival, findings from a randomized trial showed.
Patients who omitted ALND after…
Millions of breast cancer patients could safely avoid chemotherapy, study suggestsMillions of breast cancer patients could safely avoid chemotherapy, study suggests

A new DNA test could help screen whether patients require the treatment or not, according to a new international trial.